Executive Summary
Generated July 30, 2026
Legal Technology
Harvey
Strategic importance is our editorial rating of how central this entity is to the technology landscape we track; confidence reflects how well-sourced and current the underlying evidence is.
1
Chokepoint Score
1 other entity structurally depend on this one
Steady
Activity
1 recorded change in the last 90 days
Headquarters
San Francisco, California, USA
Website
Employees
400 (2026, approximate)
Founded
2022
Listing
private
Overview
An AI legal agents platform used by law firms (including Latham & Watkins) and corporate legal teams (including T-Mobile) to automate legal research, document review and drafting. Harvey raised $200 million in March 2026 co-led by GIC and Sequoia at an $11 billion valuation -- the most valuable legal technology company ever -- after reaching $190 million in annual recurring revenue and crossing $1 billion in total funding raised, up from an $8 billion valuation just three months earlier in December 2025.
Strategic Connections
- AI Legal Tech: Harvey reached an $11 billion valuation in March 2026 on $190 million in ARR, the most valuable legal technology company ever.
- Legora: Harvey competes with Legora in the AI legal agents market for law firms and corporate legal teams.
- Relativity: Harvey competes with Relativity as legal tech expands from e-discovery into broader AI-native legal workflows.
Strategic Risks
- Valuation doubled twice within roughly six months, raising sustainability and correction risk
- AI-generated legal work carries acute professional-liability and hallucination risk relative to other enterprise AI categories
Future Outlook
- Continued expansion of AI agents and embedded legal engineering teams across law firms and corporate legal departments
- Intensifying competition with Legora as both companies scale rapidly on strong ARR growth
Sources
2 sources, 56% average source confidence — full citations in the Full Analyst Report.
Generated by InsightNodes — Technology Intelligence Platform. This report reflects sourced, evidence-backed information as of the dates cited above and is not investment advice.
Viewing the Executive Summary — switch to the Full Analyst Report.